ONC seeks input on draft 2016 interoperability advisory

The Office of the National Coordinator for Health IT (ONC) is seeking public comments on the draft 2016 Interoperability Standards Advisory

Speaking at the September Health IT Policy Committee meeting, Interoperability Task Force Chair Paul Tang, MD, said the timing is right for a stronger interoperability effort because there is now a plan, motivation, incentives and the data for national interoperability. “We need the convening power of the government to spur collective action and enduring private sector business interests to sustain the effort.”

The task force also called for the development and measurement of HIE-sensitive outcomes for public reporting and payment. There is a need for transparent measures of vendor performance including the number of exchanges of external data, percentage of external data elements viewed and percentage of external data elements incorporated/reconciled, they said.

The draft 2016 Advisory represents feedback ONC received from public comment on the 2015 Interoperability Standards Advisory as well as many of the recommendations from the HIT Standards Committee, according to the announcement of its release.

"The Interoperability Standards Advisory process represents the model by which the ONC will coordinate the identification, assessment, and determination of the 'best available' interoperability standards and implementation specifications for industry use to fulfill specific clinical health IT interoperability needs," read the statement. "The 2016 Advisory remains focused on clinical health information technology interoperability.

"We need your input to improve this draft 2016 Advisory."

The comment period will be open for 45 days, ending on Friday, Nov. 6.  Public comments will be used to update this draft in order to publish a final 2016 Advisory by the end of 2015.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.